Page tree
Skip to end of metadata
Go to start of metadata

Summit 2019 was a Great Success!

On behalf of the Program Committee*, many thanks to all who participated in the first Cancer Data Summit on October 2 and 3 in McLean, Virginia. During this highly-interactive event, leaders from throughout the oncology ecosystem developed the roadmap for adoption of a common language for cancer data – mCODE, the minimal Common Oncology Data Elements standard.

Patients, providers, payers, researchers, regulators, and vendors collaborated to explore the challenges and opportunities along the path toward ubiquitous use of mCODE for data collection and sharing, leading to step-change improvements in cancer care and research.

The event ended with recommendations for actions that we can take now, including actively engaging within the new CodeX HL7 FHIR Accelerator and mCODE Council. These recommendations and more are included in the Cancer Data Summit Summary, linked from the right side of this page along with other resources from the event.

We hope these materials inspire everyone to redouble efforts toward a common language for cancer data, with outstanding achievements to be shared at Summit 2020.

If you have any questions, please contact Steve Bratt.


Below are links to the wonderful artwork our illustrators made to represent and summarize the ideas and conclusions made at the Summit. These include the large summary from Day 1 (which is also seen above) as well as the individual illustrations for each of the 4 main topics discussed during Day 2: (1) Changing Clinical Culture, (2) Convergence on a Single Standard, (3) Privacy, Security, Ethics, and (4) Vendor Implementation.

* Cancer Data Summit Program Committee
Chair: John Halamka, Harvard Medical School, Beth Israel Deaconess Medical Center; Björn Albrecht, McKinsey Cancer Center; Danielle Ciofani, Broad Institute; Carole Flamm, Blue Cross Blue Shield Association; Sean Khozin, Federal Drug Administration; Robert Miller, American Society of Clinical Oncology; Steven Piantadosi, Brigham & Women’s Hospital; Keri Reardon, Alliance for Clinical Trials in Oncology; Jay Schnitzer, MITRE; Micky Tripathi, Massachusetts eHealth Collaborative; Margaret Van Meter, Intermountain Healthcare; Debi Willis, PatientLink Enterprises; Convenor:  Steve Bratt, MITRE

  • No labels